Clinical Trial Update: Phase III Study to Evaluate Safety and Effectiveness of NOVOCART 3D Plus vs. Microfracture in Knee Cartilage Defects [Phase 3]

View source ↗

Summary

Phase III trial comparing NOVOCART 3D Plus to microfracture for traumatic articular cartilage defects in the knee has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Articular Cartilage Defects of the Knee

Drugs mentioned

• NOVOCART 3D Plus (null)

Snippet

Sponsor: Tetec AG | Conditions: Traumatic Articular Cartilage Defects in the Knee Joint | Phase 3 | Status: COMPLETED